Brain and spinal cord tumors in rats treated with pyrrolizidine alkaloids.
D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D001254:Astrocytoma / Q000139:chemically induced* / Q000473:pathology; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D007274:Injections, Intraperitoneal; D007774:Lactation; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D010264:Paraplegia / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications; D011763:Pyrrolizidine Alkaloids / Q000008:administration & dosage; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects; D013116:Spinal Cord / Q000473:pathology; D013120:Spinal Cord Neoplasms / Q000139:chemically induced* / Q000473:pathology; D001743:Urinary Bladder / Q000187:drug effects
D011763:Pyrrolizidine Alkaloids